Suppr超能文献

过度放纵与代谢综合征:FoxO1 是其中的关键环节吗?

Overindulgence and metabolic syndrome: is FoxO1 a missing link?

作者信息

Sparks Janet D, Sparks Charles E

机构信息

Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.

出版信息

J Clin Invest. 2008 Jun;118(6):2012-5. doi: 10.1172/JCI35693.

Abstract

Excessive production of triglyceride-rich VLDL, which can result from dietary overindulgence, underlies metabolic syndrome--a combination of disorders including high blood pressure, obesity, high triglyceride, and insulin resistance--and places individuals at increased risk of developing cardiovascular disease and type 2 diabetes. However, the link between VLDL overproduction and insulin resistance has remained unclear. VLDL assembly in the liver is catalyzed by microsomal triglyceride transfer protein (MTP). In this issue of the JCI, Kamagate et al. investigate the events controlling hepatic MTP expression and VLDL production and secretion (see the related article beginning on page 2347). They demonstrate that MTP is a target of the transcription factor FoxO1 and that excessive VLDL production associated with insulin resistance is caused by the inability of insulin to regulate FoxO1 transcriptional activation of MTP.

摘要

富含甘油三酯的极低密度脂蛋白(VLDL)产生过多,这可能源于饮食过度放纵,是代谢综合征的基础——代谢综合征是包括高血压、肥胖、高甘油三酯和胰岛素抵抗在内的多种疾病的组合——并使个体患心血管疾病和2型糖尿病的风险增加。然而,VLDL产生过多与胰岛素抵抗之间的联系仍不清楚。肝脏中VLDL的组装由微粒体甘油三酯转移蛋白(MTP)催化。在本期《临床研究杂志》中,卡马盖特等人研究了控制肝脏MTP表达以及VLDL产生和分泌的相关事件(见第2347页开始的相关文章)。他们证明MTP是转录因子FoxO1的一个靶点,并且与胰岛素抵抗相关的VLDL产生过多是由于胰岛素无法调节FoxO1对MTP的转录激活所致。

相似文献

1
Overindulgence and metabolic syndrome: is FoxO1 a missing link?
J Clin Invest. 2008 Jun;118(6):2012-5. doi: 10.1172/JCI35693.
2
FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice.
J Clin Invest. 2008 Jun;118(6):2347-64. doi: 10.1172/JCI32914.
3
FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.
Endocrinology. 2014 Apr;155(4):1255-67. doi: 10.1210/en.2013-1856. Epub 2014 Jan 17.
4
FoxO1 integrates insulin signaling to VLDL production.
Cell Cycle. 2008 Oct;7(20):3162-70. doi: 10.4161/cc.7.20.6882. Epub 2008 Oct 27.
7
Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia.
J Biol Chem. 2010 Aug 27;285(35):26861-26868. doi: 10.1074/jbc.M110.134023. Epub 2010 Jun 23.
8
Targeting FoxO1 for hypertriglyceridemia.
Curr Drug Targets. 2011 Aug;12(9):1245-55. doi: 10.2174/138945011796150262.

引用本文的文献

2
Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.
PLoS One. 2019 Apr 3;14(4):e0214387. doi: 10.1371/journal.pone.0214387. eCollection 2019.
3
Obesity genetics and cardiometabolic health: Potential for risk prediction.
Diabetes Obes Metab. 2019 May;21(5):1088-1100. doi: 10.1111/dom.13641. Epub 2019 Mar 20.
4
Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.
Endocr Relat Cancer. 2014 May 6;21(3):R165-82. doi: 10.1530/ERC-13-0283. Print 2014 Jun.
5
Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinases.
Biochem Biophys Res Commun. 2013 Jun 14;435(4):616-20. doi: 10.1016/j.bbrc.2013.05.029. Epub 2013 May 15.
6
Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction.
J Clin Lipidol. 2013 Jan-Feb;7(1):65-81. doi: 10.1016/j.jacl.2012.04.079. Epub 2012 Apr 22.
8
Hepatic ABCA1 and VLDL triglyceride production.
Biochim Biophys Acta. 2012 May;1821(5):770-7. doi: 10.1016/j.bbalip.2011.09.020. Epub 2011 Oct 6.
9
FoxO6 integrates insulin signaling with gluconeogenesis in the liver.
Diabetes. 2011 Nov;60(11):2763-74. doi: 10.2337/db11-0548. Epub 2011 Sep 22.
10
Acute suppression of apo B secretion by insulin occurs independently of MTP.
Biochem Biophys Res Commun. 2011 Mar 11;406(2):252-6. doi: 10.1016/j.bbrc.2011.02.028. Epub 2011 Feb 18.

本文引用的文献

1
FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice.
J Clin Invest. 2008 Jun;118(6):2347-64. doi: 10.1172/JCI32914.
2
Diurnal regulation of microsomal triglyceride transfer protein and plasma lipid levels.
J Biol Chem. 2007 Aug 24;282(34):24707-19. doi: 10.1074/jbc.M701305200. Epub 2007 Jun 15.
3
PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- mice.
Am J Physiol Gastrointest Liver Physiol. 2006 Sep;291(3):G382-8. doi: 10.1152/ajpgi.00472.2005. Epub 2006 Jun 22.
5
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia.
Atherosclerosis. 2005 Jun;180(2):311-8. doi: 10.1016/j.atherosclerosis.2004.12.004. Epub 2005 Jan 19.
7
Molecular mediators of hepatic steatosis and liver injury.
J Clin Invest. 2004 Jul;114(2):147-52. doi: 10.1172/JCI22422.
10
Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats.
Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E42-9. doi: 10.1152/ajpendo.00297.2003. Epub 2004 Feb 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验